119 related articles for article (PubMed ID: 29929138)
21. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
Szer J; Hill A; Weitz IC
Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
[TBL] [Abstract][Full Text] [Related]
22. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
Ninomiya H
Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
[TBL] [Abstract][Full Text] [Related]
24. CD59: A long-known complement inhibitor has advanced to a blood group system.
Weinstock C; Anliker M; von Zabern I
Immunohematology; 2015; 31(4):145-51. PubMed ID: 27187193
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis.
Shibuya K; Ninomiya H; Muraki Y; Nagasawa T; Abe T
Int J Hematol; 1993 Aug; 58(1-2):15-20. PubMed ID: 7693026
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria.
Kozuma Y; Sawahata Y; Takei Y; Chiba S; Ninomiya H
Br J Haematol; 2011 Mar; 152(5):631-9. PubMed ID: 21241275
[TBL] [Abstract][Full Text] [Related]
27. Adeno-associated virus mediated delivery of a non-membrane targeted human soluble CD59 attenuates some aspects of diabetic retinopathy in mice.
Adhi M; Cashman SM; Kumar-Singh R
PLoS One; 2013; 8(10):e79661. PubMed ID: 24167638
[TBL] [Abstract][Full Text] [Related]
28. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
[TBL] [Abstract][Full Text] [Related]
29. Shortened lifespan of paroxysmal nocturnal haemoglobinuria-affected RBC estimated from differences in ratios of CD59-negative populations between reticulocytes and whole RBC.
Ninomiya H; Sato S; Hasegawa Y; Nagasawa T
Int J Lab Hematol; 2008 Feb; 30(1):41-5. PubMed ID: 18190466
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.
Morgan BP
Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):409-13. PubMed ID: 1372164
[TBL] [Abstract][Full Text] [Related]
31. Use of a FLAER-based WBC assay in the primary screening of PNH clones.
Sutherland DR; Kuek N; Azcona-Olivera J; Anderson T; Acton E; Barth D; Keeney M
Am J Clin Pathol; 2009 Oct; 132(4):564-72. PubMed ID: 19762534
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
Xu C; Zhang T; Zhao R
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394
[TBL] [Abstract][Full Text] [Related]
33. An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
Ruseva MM; Ramaglia V; Morgan BP; Harris CL
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14319-24. PubMed ID: 26578778
[TBL] [Abstract][Full Text] [Related]
34. A Splice Site Mutation Associated with Congenital CD59 Deficiency.
Chai JN; Azad AK; Kuan K; Guo X; Wang Y
Hematol Rep; 2022 May; 14(2):172-178. PubMed ID: 35735736
[TBL] [Abstract][Full Text] [Related]
35. [The response of bone marrow hematopoietic cells to G-CSF in paroxysmal nocturnal hemoglobinuria patients].
Cao YR; Shao ZH; Liu H; Shi J; Bai J; Tu MF; Wang HQ; Xing LM; Cui ZZ; Sun J; Jia HR; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):235-8. PubMed ID: 15949269
[TBL] [Abstract][Full Text] [Related]
36. [STAT5 phosphorylation levels of erythropoietin and thrombopoietin receptors in CD34(+)CD59(-) and CD34(+)CD59(+) bone marrow cells of patients with paroxysmal nocturnal hemoglobinuria].
Wang D; Fu R; Ruan EB; Qu W; Liang Y; Wang HQ; Wang J; Li LJ; Liu H; Wang HL; Zhang T; Liu H; Wu YH; Xing LM; Wang GJ; Wang XM; Song J; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(30):2129-31. PubMed ID: 22093990
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
38. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
[TBL] [Abstract][Full Text] [Related]
39. [Proliferation and anti-tumor activity of lymphocytes and their effect on normal phenotype of autologous bone marrow hematopoietic cells in patients with paroxysmal nocturnal hemoglobinuria].
Wang YZ; Wu YJ; Zhang ZN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):50-3. PubMed ID: 12667290
[TBL] [Abstract][Full Text] [Related]
40. Genotypic and phenotypic implications in paroxysmal nocturnal hemoglobinuria (PNH): a preliminary investigation.
Pakdeesuwan K; Siripanyaphinyo U; Pramoonjago P; Pattanapanyasat K; Wilairat P; Kinoshita T; Wanachiwanawin W
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():58-63. PubMed ID: 9640601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
